Moreover, data from the UALCAN database suggested that the methylation levels of the EPHX4 promoter were decreased in tumor tissues (Figure 5D), a finding that was supported by the MethSurv database (Figure S5). The gene discussed is EPHX4; the disease is neoplasm.